Short-Term Outcome of Everolimus and Mizoribine Based CNI Minimization Immunosuppressant Therapy for De Novo Kidney Transplant Recipients.: Abstract# B999
2014
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI